Poseida Therapeutics (PSTX, $3.6) gained +6 and reached a new high over the last three months. By comparison, the broader Biotechnology Industry returned 2 over the same period of time. A.I.dvisor analyzed 873 stocks in the Biotechnology Industry over the same period of time and found that of them (6) were in an Uptrend while of them (3) showed a Downtrend.
a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors